https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-24 / Front Immunol 2019;10:874
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-24 / Front Immunol 2019;10:8742019-04-24 00:00:002019-04-24 00:00:00Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-532016-03-01 00:00:002019-02-15 08:48:03Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-92015-12-08 00:00:002019-02-15 08:48:02Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-02 / Expert Rev Clin Immunol 2016;12(2):91-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-02 / Expert Rev Clin Immunol 2016;12(2):91-42015-12-02 00:00:002019-02-15 08:48:04HIV immunotherapy comes of age: implications for prevention, treatment and cure
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-03-27 / PLoS Pathog. 2015 Mar;11(3):e1004752
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-03-27 / PLoS Pathog. 2015 Mar;11(3):e10047522015-03-27 00:00:002019-02-15 08:48:01Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2011-07-23 / Vaccine 2011 Sep;29(38):6454-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2011-07-23 / Vaccine 2011 Sep;29(38):6454-632011-07-23 00:00:002019-02-15 08:47:56Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-06-15 / J. Infect. Dis. 2009 Jun;199(12):1862-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-06-15 / J. Infect. Dis. 2009 Jun;199(12):1862-712009-06-15 00:00:002019-02-15 08:48:00Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-01-23 / PLoS ONE 2009;4(1):e4256
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-01-23 / PLoS ONE 2009;4(1):e42562009-01-23 00:00:002019-02-15 09:15:04In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-11-26 / Clin. Vaccine Immunol. 2009 Feb;16(2):233-40
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-11-26 / Clin. Vaccine Immunol. 2009 Feb;16(2):233-402008-11-26 00:00:002019-02-15 09:15:03Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-412008-05-20 00:00:002019-02-15 09:15:04Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef